Since intracellular levels of JNK3 are associated with cognitive performance and serve as a biomarker of synaptic dysfunction, dysregulation of JNK3 activity is associated with several neurodegenerative diseases, such as stroke, Alzheimer’s disease, Parkinson’s disease, and epilepsy. The gene discussed is MAPK10; the disease is early-onset autosomal dominant Alzheimer disease.